News About: Pharm. Industry
Yuhan establishes foundation to keep top sales position in pharma industry
Since Yuhan Corporation and Boehringer Ingelheim were agreed to renew their strategic partnership, it was anticipated Yuhan Corporation will keep its top sales position in the industry for a while.
Yuhan Corporation ...
Pharma industry’s concerns on rebates with CSO system
As it was known the police exposed illegal rebates and made a search and seizure on a distribution company, which has a directly business with a medium hospital in Gimhae, and CSOs(Contract Sales Organizations) on the...
Rapid increases in drug exportation followed by Korean pharmas’ strengthened capability
With acceleration in pioneering pharmerging and emerging markets and entering advanced biosimilar markets, this year’s amount of drug exports were anticipated to record USD 3.39 billion increased by 15.2% compared to ...
Celltrion’s Remsima challenges to Truxima’s KRW 8 trillion marketOn the 19th(local time), Celltrion announced it received ‘recommendation of approval’ for every indication of the world’s first hematological malignancy anticancer biosimilar Tr...
|
Pharmas, “Hope impacts of the prosecution’s rebate investigation will be minimum…”
‘Hope the impact will be minimum…’
Since it was known the prosecution is about to announce the final investigation result on a hospital ‘J’ located in Jeonju, pharmaceutical companies have paid attention to the resul...
Multinational pharmas turned in status of advertising expenses to MOHW
While the general administrative investigation is expected over multinational pharmaceutical companies after the Novartis’ rebate incident, it was confirmed its related data is turned in to the Ministry of Health and ...
‘Double torture’ on pharma industry
It was concerned the pharmaceutical industry is encountering a double torture, enforcement of the Kim Young-Ran Law and entry restriction from medical institutes.
According to the pharmaceutical industry, pharmaceuti...
“Zuellig have strong points, such as customer confidence, logistics system and service”Zuellig Pharma showed confidence over the pharmaceutical distribution competition in the Korean market.
At a meeting with Yakup Shinmoon, Zuellig Pharma Korea CEO Christophe Pi...
|
SK Chemicals & Lilly Korea sign co-marketing agreement of Cymbalta
On the 15th, SK Chemicals announced it signed a co-marketing agreement of the osteoarthritis pain treatment ‘Cymbalta(generic name: Duloxetine Hcl)’ for patients that have adverse reactions to antidepressants and nons...
Pharmacies’ fictitious demands aggravates burden of inventory for logistics companies
It was criticized a series of recent drug out-of-stock incidents have aggravated burden of inventory on pharmaceutical distribution companies.
According to the industry concerned, distribution companies are putting e...
